PCI Biotech (OSE: PCIB), today announces its preliminary full year 2024 results. Please find enclosed the interim r ...
Oncoinvent, a clinical-stage radiopharmaceutical company developing innovative treatments for solid cancers, today announced the successful enrollment of the sixth patient into the safety lead-in ...
The shares in TGS ASA will be traded ex dividend NOK 1.73 (USD 0.155) as from today, 27 February 2025.